318 related articles for article (PubMed ID: 19265481)
1. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination.
Madhi SA; Klugman KP; Kuwanda L; Cutland C; Käyhty H; Adrian P
J Infect Dis; 2009 Apr; 199(8):1168-76. PubMed ID: 19265481
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.
Madhi SA; Adrian P; Kuwanda L; Jassat W; Jones S; Little T; Soininen A; Cutland C; Klugman KP
Vaccine; 2007 Mar; 25(13):2451-7. PubMed ID: 17023095
[TBL] [Abstract][Full Text] [Related]
4. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
[TBL] [Abstract][Full Text] [Related]
5. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Song LY; Fenton T; Nachman SA; Levin MJ; Rosenblatt HM; Pelton SI; Borkowsky W; Edwards KM; Peters J;
Pediatrics; 2007 Nov; 120(5):e1190-202. PubMed ID: 17938165
[TBL] [Abstract][Full Text] [Related]
6. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.
Madhi SA; Cohen C; von Gottberg A
Vaccine; 2012 Sep; 30 Suppl 3():C21-7. PubMed ID: 22939016
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children.
Spoulou VI; Tsoumas DL; Papaevangelou VG; Mostrou GI; Theodoridou MC
Vaccine; 2005 Nov; 23(46-47):5289-93. PubMed ID: 16054732
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma.
Rose MA; Schubert R; Kujumdshiev S; Kitz R; Zielen S
Int J Clin Pract; 2006 Nov; 60(11):1425-31. PubMed ID: 17073839
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients.
Lu CL; Hung CC; Chuang YC; Liu WC; Su CT; Hsiao CF; Tseng YT; Su YC; Chang SF; Chang SY; Chang SC
Vaccine; 2012 May; 30(24):3526-33. PubMed ID: 22484349
[TBL] [Abstract][Full Text] [Related]
10. A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.
Hung CC; Chang SY; Su CT; Chen YY; Chang SF; Yang CY; Liu WC; Wu CH; Chang SC
HIV Med; 2010 Jan; 11(1):54-63. PubMed ID: 19659943
[TBL] [Abstract][Full Text] [Related]
11. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults.
Chen M; Ssali F; Mulungi M; Awio P; Yoshimine H; Kuroki R; Furumoto A; Tanimura S; Kityo C; Nagatake T; Mugyenyi P; Oishi K
Vaccine; 2008 Sep; 26(38):4962-8. PubMed ID: 18639599
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
[TBL] [Abstract][Full Text] [Related]
13. Anamnestic immune response in 3- to 4-year-old children previously immunized with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine as 2-dose or 3-dose priming and a booster dose in the first year of life.
Silfverdal SA; Skerlikova H; Zanova M; Papúchová D; Traskine M; Borys D; Schuerman L
Pediatr Infect Dis J; 2011 Sep; 30(9):e155-63. PubMed ID: 21572373
[TBL] [Abstract][Full Text] [Related]
14. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
16. Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.
Huebner RE; Mbelle N; Forrest B; Madore DV; Klugman KP
Vaccine; 2004 Jul; 22(21-22):2696-700. PubMed ID: 15246599
[TBL] [Abstract][Full Text] [Related]
17. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults.
French N; Moore M; Haikala R; Kayhty H; Gilks CF
J Infect Dis; 2004 Aug; 190(4):707-12. PubMed ID: 15272398
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics.
Rose MA; Gruendler M; Schubert R; Kitz R; Schulze J; Zielen S
Vaccine; 2009 Aug; 27(38):5259-64. PubMed ID: 19576944
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy.
Tangsinmankong N; Kamchaisatian W; Day NK; Sleasman JW; Emmanuel PJ
Ann Allergy Asthma Immunol; 2004 May; 92(5):558-64. PubMed ID: 15191025
[TBL] [Abstract][Full Text] [Related]
20. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.
Ditse Z; Adrian PV; Kuwanda L; Madhi SA
Vaccine; 2013 Sep; 31(40):4421-7. PubMed ID: 23845819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]